大肠直肠癌治疗市场：依治疗类型、给药途径、通路及地区划分

大肠直肠癌治疗市场预计到2024年将达到89.8亿美元，预计到2031年将达到121亿美元，2024年至2031年的复合年增长率为4.3%。

图：2024 年按地区分類的结直肠癌治疗药物市场占有率（%）

大肠直肠癌是世界上最常见的癌症之一，也是癌症相关死亡的主要原因。根据世界卫生组织（WHO）统计，2020年全球将有超过190万人新诊断出大肠癌，每年将有超过90万人死于大肠癌。大肠直肠癌盛行率的增加和有限的治疗选择增加了对有效治疗药物的需求。多家生物製药公司致力于开发新型标靶治疗方法，例如标靶单株抗体、蛋白激酶抑制剂和免疫查核点抑制剂，以治疗大肠直肠癌。

市场动态

全球大肠直肠癌治疗市场的成长是由全球大肠癌盛行率上升所推动的。据美国癌症协会称，2020年美国每年将诊断出超过15万例大肠癌新病例。此外，政府和癌症组织越来越多地倡议来提高人们对大肠癌早期检测和治疗的认识，这可能会推动市场成长。然而，新型标靶治疗的高成本可能会阻碍其广泛使用。持续研究和开发新一代生物标记引导的个人化疗法可能会创造利润丰厚的成长机会。

本研究的主要特点

该报告对全球结直肠癌治疗药物市场进行了详细分析，并列出了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球结直肠癌治疗市场的主要企业进行了分析。

本研究涵盖的主要企业包括赛诺菲、百时美施贵宝公司、拜耳公司、小野製药有限公司、ALX Oncology Inc.、第一三共有限公司、辉瑞公司、Exelixis, Inc.、SOTIO Biotech AG 、AB Science、BioNTech SE、Effector Therapeutics, Inc. 和Treos Bio Limited。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球结直肠癌治疗药物市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。

透过用于分析全球大肠直肠癌治疗药物市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 流行病学
• 管道分析

第四章大肠直肠癌治疗药物市场，依治疗类型，2019-2031

• 化疗
• 免疫疗法
• 标靶治疗
• 其他的

第五章大肠直肠癌治疗市场，依给药途径，2019-2031

• 口服
• 静脉
• 肌肉注射
• 皮下的
• 其他的

第六章 2019-2031 年大肠直肠癌治疗药物市场（依通路）

• 医院药房
• 零售药房
• 网路药房

第七章2019-2031年大肠直肠癌治疗药物市场（依地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• Sanofi
• Bristol-Myers Squibb Company
• Bayer AG
• Ono Pharmaceutical Co. Ltd
• ALX Oncology Inc.
• Daiichi Sankyo Company, Limited
• Pfizer Inc.
• Exelixis, Inc.
• SOTIO Biotech AG
• AB Science
• BioNTech SE
• Effector Therapeutics, Inc.
• Treos Bio Limited

第九章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第10章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Colorectal cancer therapeutics market is estimated to be valued at USD 8.98 Bn in 2024 and is expected to reach USD 12.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.

Figure. Colorectal Cancer Therapeutics Market Share (%), By Region, 2024

Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-related mortality. According to World Health Organization (WHO), in 2020, over 1.9 million new cases of colorectal cancer are diagnosed globally and more than 0.9 million deaths due to colorectal cancer occur annually. Rising prevalence of colorectal cancer and limited treatment options have boosted demand for effective therapeutics. Several biopharma companies are focusing on developing novel targeted therapeutic approaches such as targeted monoclonal antibodies, protein kinase inhibitors, and immune checkpoint inhibitors to treat colorectal cancer.

Market Dynamics

Global colorectal cancer therapeutics market growth is driven by rising prevalence of colorectal cancer worldwide. In 2020, according to the American Cancer Society, over 150,000 new cases of colorectal cancer are diagnosed in the U.S. every year. Moreover, increasing initiatives by governments and cancer organizations to spread awareness about early detection and treatment of colorectal cancer can drive the market growth. However, high costs associated with novel targeted therapies can hamper its widespread adoption. Ongoing research & development for developing new generation biomarker-guided personalized therapies can create lucrative growth opportunities.

Key features of the study

This report provides in-depth analysis of the global colorectal cancer therapeutics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global colorectal cancer therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Sanofi, Bristol-Myers Squibb Company, Bayer AG, Ono Pharmaceutical Co. Ltd, ALX Oncology Inc., Daiichi Sankyo Company, Limited, Pfizer Inc., Exelixis, Inc., SOTIO Biotech AG, AB Science, BioNTech SE, Effector Therapeutics, Inc., and Treos Bio Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global colorectal cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer therapeutics market

Market Segmentation

• Therapy Type Insights (Revenue, USD, 2019 - 2031)
  • Chemotherapy
  • Alkylating Agents
  • Antimetabolites
  • Others
  • Immunotherapy
  • Immune Checkpoint Inhibitors
  • Oncolytic Virus Therapy
  • Others
  • Targeted Therapy
  • Monoclonal antibodies
  • Small molecule inhibitors
  • Others
• Route of Administration Insights (Revenue, USD, 2019 - 2031)
  • Oral
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others
• Distribution Channel Insights
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Sanofi
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Ono Pharmaceutical Co. Ltd
  • ALX Oncology Inc.
  • Daiichi Sankyo Company, Limited
  • Pfizer Inc.
  • Exelixis, Inc.
  • SOTIO Biotech AG
  • AB Science
  • BioNTech SE
  • Effector Therapeutics, Inc.
  • Treos Bio Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Colorectal Cancer Therapeutics Market, By Therapy Type
  • Colorectal Cancer Therapeutics Market, By Route of Administration
  • Colorectal Cancer Therapeutics Market, By Distribution Channel
  • Colorectal Cancer Therapeutics Market, Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Epidemiology
• Pipeline Analysis

4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Chemotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Alkylating Agents
  • Antimetabolites
  • Others
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immune Checkpoint Inhibitors
  • Oncolytic Virus Therapy
  • Others
• Targeted Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Monoclonal antibodies
  • Small molecule inhibitors
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Subcutaneous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Colorectal Cancer Therapeutics Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol-Myers Squibb Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ono Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ALX Oncology Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Daiichi Sankyo Company, Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Exelixis, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SOTIO Biotech AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Science
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioNTech SE
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Effector Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Treos Bio Limited

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us